Search - tctmd.com

Displaying 41 - 60 of 70

Sort: Relevancy | Date

News Daily News

Pollution Deserves More Attention in Cardiology—and More Action

Yael L. Maxwell

June 03, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

News Conference News HRS 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

Michael O'Riordan

May 23, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Daily News

Time-Restricted Eating, High-Intensity Training Have Heart Benefits for Obese Women

Todd Neale

May 07, 2024

News Daily News

Wearable-Tracked Walking Behavior Hints at Subclinical HF

Caitlin E. Cox

April 23, 2024

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Conference News ACC 2024

HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players

Michael O'Riordan

April 15, 2024

News Conference News EHRA 2024

Stroke Rates Fall Among AF Patients Not on Anticoagulation

Todd Neale

April 11, 2024

News Conference News ACC 2024

BE ACTIVE: Gaming for Points and Money Can Boost Step Counts

L.A. McKeown

April 11, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Daily News

Climbing Everest? Cardiac Arrhythmias Join Other Fabled Risks

Michael O'Riordan

April 04, 2024

News Conference News ACC 2024

Faster CAC Progression After Menopause May Warrant Intensified Therapy

L.A. McKeown

April 04, 2024

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

Todd Neale

March 08, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Transcatheter pulmonary artery banding [PAB] for HFrEF: Initial results of invasive exercise hemodynamics and updates from the ongoing First-in-Human trial.

Presenter: Sean P. Pinney

March 06, 2024

Advertisement

Pollution Deserves More Attention in Cardiology—and More Action

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Time-Restricted Eating, High-Intensity Training Have Heart Benefits for Obese Women

Wearable-Tracked Walking Behavior Hints at Subclinical HF

INOCA May Be at the Root of Angina for Many Long-COVID Patients

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players

Stroke Rates Fall Among AF Patients Not on Anticoagulation

BE ACTIVE: Gaming for Points and Money Can Boost Step Counts

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Climbing Everest? Cardiac Arrhythmias Join Other Fabled Risks

Faster CAC Progression After Menopause May Warrant Intensified Therapy

FDA Grants MACE Reduction Indication for Semaglutide

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Transcatheter pulmonary artery banding [PAB] for HFrEF: Initial results of invasive exercise hemodynamics and updates from the ongoing First-in-Human trial.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content